Navigation Links
Quantros Expands RRM Solution With New Quality Measures
Date:10/8/2009

SAN FRANCISCO, Oct. 8 /PRNewswire/ -- Quantros, a leading provider of safety and quality software and professional services solutions for the healthcare industry, today announced significant updates to its Regulatory Reporting Management(TM) (RRM) hospital performance improvement solution to coincide with National Hospital Quality Measures (NHQM) updates for October 2009 discharges.

Quantros RRM will now include expanded tracking of venous thromboembolism (VTE) and emergency department (ED) measures endorsed by The Joint Commission (TJC). Surgical Care Improvement Project (SCIP) quality indicators, including Inf-9 for postoperative urinary catheter removal and Inf-10 for perioperative temperature management, will also be incorporated within the Quantros RRM solution suite.

"Our goal is to help our customers improve patient safety and quality performance," said Quantros CEO and CMO Sanjaya Kumar, MD, MPH. "We continuously update the RRM suite to maintain compliance with TJC and Core Measures standards and maximize its value to our customers on an ongoing basis."

Quantros RRM already complies with Center for Medicare and Medicaid Services (CMS) 2010 RHQDAPU measures and supports participation in systematic clinical database registries for cardiac surgery and stroke. Although neither the VTE nor ED data sets are required Core Measures, they will be tracked to provide RRM users with the most comprehensive, up-to-date compliance data available.

Existing Quantros RRM customers already receiving the benefits of an integrated platform will receive some of the expanded capabilities at no additional charge. By providing real-time access to a broad range of regulatory data and performance improvement tools, RRM users can cost effectively maintain compliance to improve care delivery.

Quantros is a leading software and services provider for the healthcare industry in the areas of safety and risk management,
'/>"/>

SOURCE Quantros
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
2. Quantros Expanding Support for Alternative Web Browsers
3. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
4. Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
5. Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety
6. Quantros and ISMP to Partner on PSO Initiatives
7. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
8. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7
9. Quantros President Appears on National TV Promoting Patient Safety
10. The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager
11. Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadin... today announced the expansion of its services to ... Dr. Doug Macmillan. , ... pleased to announce that Dr. Doug Macmillan, an e... an additional advanced training seminar. RTDenta...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceu...panywillhosttwoinvestoreventsinDecember: ,, A...00a.m.ET ,, Principalinvestigatorswilldiscuss...nd/orrefractorymultiplemyeloma,asfeaturedatthe51st...positioninNewOrleans,LA.Theteleconferencewillbegin...
(Date:11/25/2009)...v.25/PRNewswire-USNewswire/--TheBlackAIDSInstitute...cutiveleadershipfor2010. ,, ThenewBoardMembersa...licpolicy,law,finance,governmenthealthprograms,edi...esfromawiderangeofpersonalbackgroundsincludingboth...IVthemselves,andrepresentingmultipleagegroups. ,...
(Date:11/25/2009)...overy that grew out of a collaboration between UCL... hope to the nearly 10 million Americans who suffe...nown as hardening of the arteries, peripheral arte...lem in which narrowed arteries reduce blood flow t...g for vascular disease, heart attack and stroke, a...
(Date:11/25/2009)...s could lead mothers to overlook needed care, stud...y News) -- A mother,s depression can worsen her ch...eir six-month study of 262 black mothers and their...re depressive symptoms had more frequent asthma sy...ssive symptoms had less frequent asthma symptoms. ...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
...co, Inc. is,pleased to announce the introduction o...rapid point of care system utilizes a chemilumines...separation method that allows,this system to repor...ole blood sample., The PATHFAST system can handle...
..., Inc.,(the "Company") (Nasdaq: AFAM ) announced ...public offering price of $17.75 per share. In conn...as been granted an option to,purchase up to 337,50...fering, after underwriting discounts,and estimated...
...heterogeneous group and may not always be associat...he study of 145 triple negative breast cancers (i....gesterone receptor-negative and HER2-negative) in ...of the study. , Triple negative breast cancer i...
...l can detect prostate cancer and provide undistort...te tumor localization, according to a recent study...ersity in Columbus, OH. , The 3T MRI datasets we... an endorectal coil leads to deformation of the pr...
...confirming large bowel obstruction and identifying... recent study conducted by researchers at the Univ...There is very little published evidence regarding ...n clinical problem and plain films have been shown...
...h 3T MR-guided focused ultrasound (MRgFUS) is safe...t study conducted by researchers at Weill Cornell ...25% of women in the United States have clinically ...n developed in radiology, includingnon-invasive MR...
Other Medicine News:Health News:Almost Family Announces Pricing of 2,250,000 Common Shares 2Health News:CT useful and effective when diagnosing patients with large bowel obstruction 2
(Date:11/25/2009)...wswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),...overing,developingandcommercializingnoveldrugstotr...iscalyearendedSeptember30,2009.AtSeptember30,2009P...shortterminvestments. ,, PipelineUpdateand2009...,, InlateNovember2009,anindependentDataMonitori...
(Date:11/25/2009)...PRNewswire-FirstCall/--Formanyofthemillionsofheari...thuntreated hearingloss ,theholidaysmaynotbealltha...eniorvicepresidentofHearUSA(Amex: EAR ),oneofAmeri...idstudieshavelinkedhearinglosstostress,frustration...holidaygatheringswithfamiliesandfriends,whenmanyof...
(Date:11/25/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...sDentalDevicesMarketAnalysisandForecaststo2015 ,...tates-Dental-Devices-Market-Analysis-and-Forecasts...etAnalysisandForecaststo2015 ,, Summary ,,...onanddatarelatingtotheUSdentaldevicesmarket.Italso...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Elsevier Announces 2008 Journal Impact Factor Highlights 50255 1Elsevier Announces 2008 Journal Impact Factor Highlights 50255 2Elsevier Announces 2008 Journal Impact Factor Highlights 50255 3Medicsight Launches ColonCAD 28TM 29 Online CTC Platform 50253 1Medicsight Launches ColonCAD 28TM 29 Online CTC Platform 50253 2Medicsight Launches ColonCAD 28TM 29 Online CTC Platform 50253 3Biostar Pharmaceuticals Inc Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base 50251 1Biostar Pharmaceuticals Inc Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base 50251 2Biostar Pharmaceuticals Inc Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base 50251 3
...007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) tod...tudy of Proellex in the treatment of,endometriosis...menopausal women and has completed six months of d...ellex(TM) as well as a,positive control arm. The p... known as Lupron(R) or leuprolide acetate, commonl...
...- Accera, Inc.,today is presenting data from an op... of AC-1202 (Ketasyn) in Alzheimer,s disease (AD),...ference on,Prevention of Dementia in Washington, D...al and preclinical studies, AC-1202 was,shown to b...,cognition of subjects of a particular pharmacogen...
Other Medicine Technology:Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
Lorenz 2.0 mm Flexible Titanium
Craniofix Titanium Clamp
...e Cfix cable fixation system is a flexible titaniu...crimping and address the surgeon's need for intrao... provides the surgeon with the ability to retighte...tting without the need for additional cables. Quic...
Grafton DBM Crunch
Medicine Products: